Heartburn help for pharmacists
This article was originally published in The Tan Sheet
Executive Summary
American Pharmaceutical Association's "Strategies for the Self-Treatment of Heartburn" developed to provide pharmacists with tools to compare and contrast OTC drugs "that self-treating patients can use to manage heartburn" and identify self-treating patients "who would benefit from a diagnostic evaluation by a physician," APhA says. Guide was supported by a grant from P&G, which is seeking to market AstraZeneca's Prilosec OTC...
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.